Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility
중증 COVID-19 환자를 위한 세포 기반 치료: 임상 시험 및 비용 활용
Review
[키워드] Abstract
acute respiratory distress
acute respiratory distress syndrome
antigen recognition
approach
approved
Cell
Cell therapy
Cell-based therapy
cellular
clinical
clinical study
clinical trial
clinical trials
cost
country
COVID-19
decrease
dendritic cells
develop
Exosome
Exosomes
Government
immune response
immune system
Immunotherapy
infected cells
Inflammatory
introduced
mesenchymal stem cell
Mesenchymal stem cells
moderate
moderate to severe
MSC
MSCs
natural
outcomes
pandemic
promote
regulate
respiratory distress
resulting
stem cell
stimulate
syndrome
T cell
T cells
Therapeutics
therapy
treating COVID-19
treating COVID-19 patient
Treatment
Trial
Vaccine
Viral
viral disease
Viral diseases
viral infections
virus-infected cell
virus-infected cells
[DOI] 10.1007/s12015-020-10046-1 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s12015-020-10046-1 PMC 바로가기 [Article Type] Review